Effects of esmolol on haemodynamic response to CO2 pneumoperitoneum for laparoscopic surgery

被引:45
作者
Koivusalo, AM
Scheinin, M
Tikkanen, I
Yli-Suomu, T
Ristkari, S
Laakso, J
Lindgren, L
机构
[1] Univ Helsinki, Cent Hosp, Dept Anaesthesia, SF-00130 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Surg 4, SF-00130 Helsinki, Finland
[3] Univ Turku, Dept Pharmacol & Clin Pharmacol, SF-20500 Turku, Finland
[4] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland
[5] Mineral Labs, Helsinki, Finland
[6] Paijat Hame Cent Hosp, Dept Anaesthesia, Lahti, Finland
[7] Paijat Hame Cent Hosp, Dept Surg, Lahti, Finland
关键词
Esmolol; laparoscopy; hemodynamics; carbon dioxide; renal function;
D O I
10.1111/j.1399-6576.1998.tb05159.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Carbon dioxide (CO2) pneumoperitoneum for laparoscopic surgery increases arterial pressures, systemic vascular resistance and heart rate and decreases urine output. Methods: In this double-blind randomized study esmolol, an ultrashort-acting beta 1-adrenoceptor antagonist was compared with physiological saline (control) in 28 patients undergoing laparoscopic surgery in standardized 1 MAC isoflurane anaesthesia. Alfentanil infusion was used to prevent the increase of mean arterial pressure more than 25% from baseline. Results: Esmolol effectively prevented the presser response to induction and maintenance of CO2 pneumoperitoneum. Significantly (P<0.001) less alfentanil was needed in the esmolol group than in the control group. Urine output was higher (P<0.05) and plasma renin activity (P<0.01) and urine N-acetyl-beta-D-glucosaminidase levels lower in the esmolol group when compared with the control group. Conclusions: Esmolol blunts the presser response to induction and maintenance of pneumoperitoneum and may protect against renal ischaemia during pneumoperitoneum.
引用
收藏
页码:510 / 517
页数:8
相关论文
共 38 条
[1]   THE PREOPERATIVE AND INTRAOPERATIVE HEMODYNAMIC PREDICTORS OF POSTOPERATIVE MYOCARDIAL-INFARCTION OR ISCHEMIA IN PATIENTS UNDERGOING NONCARDIAC SURGERY [J].
CHARLSON, ME ;
MACKENZIE, CR ;
GOLD, JP ;
ALES, KL ;
TOPKINS, M ;
FAIRCLOUGH, GP ;
SHIRES, GT .
ANNALS OF SURGERY, 1989, 210 (05) :637-648
[2]   THE EFFECT OF ESMOLOL GIVEN DURING CARDIOPULMONARY BYPASS [J].
CORK, RC ;
KRAMER, TH ;
DREISCHMEIER, B ;
BEHR, S ;
DINARDO, JA .
ANESTHESIA AND ANALGESIA, 1995, 80 (01) :28-40
[3]  
COWLEY AW, 1988, HYPERTENSION, V11, P25
[4]  
FEIG BW, 1994, SURGERY, V116, P733
[5]  
FISHMAN AP, 1974, NEW ENGL J MED, V291, P953, DOI 10.1056/NEJM197410312911808
[6]   HYPERCARBIA DURING CARBON-DIOXIDE PNEUMOPERITONEUM [J].
FITZGERALD, SD ;
ANDRUS, CH ;
BAUDENDISTEL, LJ ;
DAHMS, TE ;
KAMINSKI, DL .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (01) :186-190
[7]  
FREEMAN R, 1983, HYPERTENSION PHYSIOP, P225
[8]   COMPARISON OF THE EFFICACY OF ESMOLOL AND ALFENTANIL TO ATTENUATE THE HEMODYNAMIC-RESPONSES TO EMERGENCE AND EXTUBATION [J].
FUHRMAN, TM ;
EWELL, CL ;
PIPPIN, WD ;
WEAVER, JM .
JOURNAL OF CLINICAL ANESTHESIA, 1992, 4 (06) :444-447
[9]  
GHONEIM MM, 1992, ANESTHESIOLOGY, V76, P279
[10]   USE OF ESMOLOL DURING ANESTHESIA TO TREAT TACHYCARDIA AND HYPERTENSION [J].
GOLD, MI ;
SACKS, DJ ;
GROSNOFF, DB ;
HERRINGTON, C ;
SKILLMAN, CA .
ANESTHESIA AND ANALGESIA, 1989, 68 (02) :101-104